121 related articles for article (PubMed ID: 38682208)
1. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway.
Wu S; Cai W; Shi Z; Ming X; Yang X; Zhou Y; Chen X; Yang M
Biochem Biophys Res Commun; 2022 Jul; 614():47-55. PubMed ID: 35567943
[TBL] [Abstract][Full Text] [Related]
3. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
4. Dehydrocrenatidine extracted from
Hsieh MC; Lo YS; Chuang YC; Lin CC; Ho HY; Hsieh MJ; Lin JT
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34165177
[TBL] [Abstract][Full Text] [Related]
5. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Suppresses Human Nasopharyngeal Carcinoma Cell Growth Via Inhibiting Differentiation Antagonizing Non-Protein Coding RNA (DANCR) Expression.
Zhang J; Jin X; Zhou C; Zhao H; He P; Hao Y; Dong Q
Med Sci Monit; 2020 Jul; 26():e923622. PubMed ID: 32683392
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
[TBL] [Abstract][Full Text] [Related]
8. Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.
Luo S; Huang G; Wang Z; Wan Z; Chen H; Liao D; Chen C; Li H; Li B; Chen L; Huang Z; He Z
Int J Clin Exp Pathol; 2015; 8(9):9990-10001. PubMed ID: 26617707
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma.
Chiang C; Zhang M; Wang D; Xiao T; Zhu L; Chen K; Huang J; Huang J; Zhu J; Li L; Chen C; Chen Y; Hu H; Jiang W; Zou Y; Wang T; Zheng D
Theranostics; 2020; 10(17):7906-7920. PubMed ID: 32685028
[No Abstract] [Full Text] [Related]
10. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
11. Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells.
Zhou C; Shen G; Yang F; Duan J; Wu Z; Yang M; Liu Y; Du X; Zhang X; Xiao S
J Cell Mol Med; 2020 Jun; 24(11):6438-6447. PubMed ID: 32307891
[TBL] [Abstract][Full Text] [Related]
12. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
13. STRESS granule-associated RNA-binding protein CAPRIN1 drives cancer progression and regulates treatment response in nasopharyngeal carcinoma.
Yang T; Huang L; Qin H; Mai S
Med Oncol; 2022 Dec; 40(1):47. PubMed ID: 36515758
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid phenethyl ester suppressed growth and metastasis of nasopharyngeal carcinoma cells by inactivating the NF-κB pathway.
Liang Y; Feng G; Wu L; Zhong S; Gao X; Tong Y; Cui W; Qin Y; Xu W; Xiao X; Zhang Z; Huang G; Zhou X
Drug Des Devel Ther; 2019; 13():1335-1345. PubMed ID: 31118570
[No Abstract] [Full Text] [Related]
15. Cytokeratin 13 promotes radiotherapy sensitivity of nasopharyngeal carcinoma by downregulating the MEK/ERK pathway.
Shi M; Wan J; Wang H; Yu H
IUBMB Life; 2022 Jun; 74(6):543-553. PubMed ID: 35426961
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of KLF5 by EBER1 via the ERK signaling pathway in EBV-positive nasopharyngeal carcinoma cells: implications for latent EBV infection.
Hu J; Xin F; Liu W; Gong Z; Zhang Y; Liu S
J Gen Virol; 2024 May; 105(5):. PubMed ID: 38747699
[TBL] [Abstract][Full Text] [Related]
17. Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
Fan CW; Tang J; Jiang JC; Zhou MM; Li MS; Wang HS
Phytomedicine; 2022 Jul; 102():154192. PubMed ID: 35636179
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Inhibits Proliferation of Epstein-Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression.
Liu L; Yang J; Ji W; Wang C
Biomed Res Int; 2019; 2019():8592921. PubMed ID: 31687403
[TBL] [Abstract][Full Text] [Related]
19. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
20. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
